Strain-specific pre-existing immunity: A key to understanding the role of chronic Toxoplasma infection in cognition and Alzheimer's diseases?

Neurosci Biobehav Rev. 2022 Jun:137:104660. doi: 10.1016/j.neubiorev.2022.104660. Epub 2022 Apr 9.

Abstract

Toxoplasma exposure can elicit cellular and humoral immune responses. In the case of chronic Toxoplasma infection, these immune responses are long-lasting. Some studies suggest that pre-existing immunity from Toxoplasma infection can shape immune responses and resistance to other pathogens and brain insults later in life. Much evidence has been generated suggesting Toxoplasma infection may contribute to cognitive impairment in the elderly. However, there have also been studies that disagree with the conclusion. Toxoplasma has many strain types, with virulence being the most notable difference. There is also considerable variation in the outcomes following Toxoplasma exposure ranging from resolved to persistent infection. Therefore, the brain microenvironment, particularly cellular constituents, differs based on the infecting strain (virulent versus hypovirulent) and infection stage (resolved versus persistent). Such difference might play a critical role in determining the outcome of the host on subsequent challengings to the brain. The ability of Toxoplasma strains to set up distinct stages for neurodegenerative pathology through varying degrees of virulence provides unique experimental tools for characterizing these pathways.

Keywords: Alzheimer’s disease (AD); Exacerbate; Hypovirulent strain; Immunosuppression; Low-grade inflammation; Pre-existing immunity; Protection; Subsequent brain insults; Toxoplasma gondii (T. gondii); Variable outcomes following infection; Virulent strain.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alzheimer Disease*
  • Cognition
  • Humans
  • Immunity
  • Toxoplasma* / physiology
  • Virulence